Letter From American Cancer Society Cancer Action Network (ACS CAN)
METAvivor Signs On to Remove Financial Barriers to Clinical Trials METAvivor has joined 128 other patient advocacy groups, public health organizations, and professional societies in urging the U.S. Department of […]
Challenge to Grant Review Process Sought by OMB-2026-0034
METAvivor submitted a formal response to OMB-2026-0034 opposing proposed changes to federal research funding. METAvivor submitted a formal response to the Office of Management and Budget regarding the proposed Uniform […]
Support Legislation Removing Barriers to Clinical Trials
METAvivor signed onto a letter supporting the Clinical Trial Modernization Act. METAvivor has joined nearly 200 patient advocacy, public health, and health care organizations in supporting the bipartisan Clinical Trial […]
Letter from Alliance for Breast Cancer Policy
METAvivor Leads the Call for Better Cancer Registry Data As a proud Steering Committee member of the Alliance for Breast Cancer Policy, METAvivor was proud to sign on to this […]
June 11 PCORI Letter from METAvivor
METAvivor speaks out against proposed elimination of funding for the PCORI Trust Fund. PCORI’s patient-centered research fills a critical gap in the research landscape for the MBC community. Read the […]
June 11 Registries Letter from METAvivor
METAvivor is weighing in to make sure Congress supports America’s Cancer Registries as they set funding levels for 2027. Consistent and strong support for these registries is essential in our […]